271 related articles for article (PubMed ID: 30096879)
21. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
[TBL] [Abstract][Full Text] [Related]
22. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
[TBL] [Abstract][Full Text] [Related]
23. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping.
Parkin NT; Avila-Rios S; Bibby DF; Brumme CJ; Eshleman SH; Harrigan PR; Howison M; Hunt G; Ji H; Kantor R; Ledwaba J; Lee ER; Matías-Florentino M; Mbisa JL; Noguera-Julian M; Paredes R; Rivera-Amill V; Swanstrom R; Zaccaro DJ; Zhang Y; Zhou S; Jennings C
Viruses; 2020 Jun; 12(7):. PubMed ID: 32605062
[TBL] [Abstract][Full Text] [Related]
24. Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance.
Ji H; Li Y; Graham M; Liang BB; Pilon R; Tyson S; Peters G; Tyler S; Merks H; Bertagnolio S; Soto-Ramirez L; Sandstrom P; Brooks J
Antivir Ther; 2011; 16(6):871-8. PubMed ID: 21900719
[TBL] [Abstract][Full Text] [Related]
25. Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort.
Jair K; McCann CD; Reed H; Castel AD; Pérez-Losada M; Wilbourn B; Greenberg AE; Jordan JA;
PLoS One; 2019; 14(4):e0214820. PubMed ID: 30964884
[TBL] [Abstract][Full Text] [Related]
26. Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management.
Bon I; Alessandrini F; Borderi M; Gorini R; Re MC
New Microbiol; 2007 Jul; 30(3):313-7. PubMed ID: 17802917
[TBL] [Abstract][Full Text] [Related]
27. External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.
Lee ER; Gao F; Sandstrom P; Ji H
Viruses; 2020 May; 12(5):. PubMed ID: 32429382
[TBL] [Abstract][Full Text] [Related]
28. Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients.
Devereux HL; Loveday C; Youle M; Sabin CA; Burke A; Johnson M
AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1025-30. PubMed ID: 10933616
[TBL] [Abstract][Full Text] [Related]
29. Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.
Boltz VF; Rausch J; Shao W; Hattori J; Luke B; Maldarelli F; Mellors JW; Kearney MF; Coffin JM
Retrovirology; 2016 Dec; 13(1):87. PubMed ID: 27998286
[TBL] [Abstract][Full Text] [Related]
30. Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance.
Raymond S; Nicot F; Abravanel F; Minier L; Carcenac R; Lefebvre C; Harter A; Martin-Blondel G; Delobel P; Izopet J
J Clin Virol; 2020 Jan; 122():104229. PubMed ID: 31809945
[TBL] [Abstract][Full Text] [Related]
31. Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure.
Mohamed S; Penaranda G; Gonzalez D; Camus C; Khiri H; Boulmé R; Sayada C; Philibert P; Olive D; Halfon P
AIDS; 2014 Jun; 28(9):1315-24. PubMed ID: 24698843
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.
Ávila-Ríos S; García-Morales C; Matías-Florentino M; Romero-Mora KA; Tapia-Trejo D; Quiroz-Morales VS; Reyes-Gopar H; Ji H; Sandstrom P; Casillas-Rodríguez J; Sierra-Madero J; León-Juárez EA; Valenzuela-Lara M; Magis-Rodríguez C; Uribe-Zuñiga P; Reyes-Terán G;
Lancet HIV; 2016 Dec; 3(12):e579-e591. PubMed ID: 27658867
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.
Perrier M; Désiré N; Storto A; Todesco E; Rodriguez C; Bertine M; Le Hingrat Q; Visseaux B; Calvez V; Descamps D; Marcelin AG; Charpentier C
PLoS One; 2018; 13(6):e0198334. PubMed ID: 29856864
[TBL] [Abstract][Full Text] [Related]
34. Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.
Bonifacio MA; Genchi C; Lagioia A; Talamo V; Volpe A; Mariggiò MA
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269868
[TBL] [Abstract][Full Text] [Related]
35. Different resistance mutations can be detected simultaneously in the blood and the lung of HIV-1 infected individuals on antiretroviral therapy.
White NC; Israel-Biet D; Coker RJ; Mitchell DM; Weber JN; Clarke JR
J Med Virol; 2004 Mar; 72(3):352-7. PubMed ID: 14748057
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory.
Ram D; Leshkowitz D; Gonzalez D; Forer R; Levy I; Chowers M; Lorber M; Hindiyeh M; Mendelson E; Mor O
J Virol Methods; 2015 Feb; 212():12-6. PubMed ID: 25445792
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
[TBL] [Abstract][Full Text] [Related]
38. The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran.
Golmohammadi R; Baesi K; Moradi A; Farrokhi M; McFarland W; Parsamajd S
Intervirology; 2017; 60(1-2):33-37. PubMed ID: 28795954
[TBL] [Abstract][Full Text] [Related]
39. Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.
Nicot F; Jeanne N; Raymond S; Delfour O; Carcenac R; Lefebvre C; Sauné K; Delobel P; Izopet J
J Med Virol; 2018 Sep; 90(9):1486-1492. PubMed ID: 29750364
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of polymorphisms in the HIV type 1 pol gene in the proviral DNA and viral RNA in the peripheral compartment.
Rangel HR; Garzaro D; Fabro R; Fernández D; Gutiérrez CR; Martínez N; Pujol FH
AIDS Res Hum Retroviruses; 2009 Aug; 25(8):837-41. PubMed ID: 19678769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
